Opinion takes from our editorial desk.
135 articles
The market is still pricing AI like a single data-center semiconductor trade, even as the next monetization battleground shifts toward local inference on PCs, phones, and edge devices. Nvidia’s June 1 PC AI chip launch matters less as another win for **NVDA** than as proof that AI is moving closer to the user — and that broadens the winner set.
Forgent Power’s rally looks earned, not accidental. Record bookings, a 2.3x book-to-bill ratio, and raised full-year guidance say FPS is becoming a real AI and grid infrastructure growth story before the broader market fully prices it in.
MACOM’s pullback looks like valuation panic, not a broken story. Revenue, margins, and next-quarter guidance all point to an AI-networking analog winner still accelerating.
AST SpaceMobile is still trading like the hard part is done, even though the next real proof point is a mid-June launch that has to work. Today’s drop reinforces the point: this is still a milestone stock, not a proven operating business.
Tower Semiconductor just turned AI-photonics demand into signed 2027 revenue and cash in hand, yet the stock dropped 7.4% anyway. That looks like a market misread when $1.3 billion of contracts and $290 million of prepayments have already moved this story beyond hype.
Investors are still treating tariffs like a temporary headline risk when the more important story is the interaction between sticky price pressure, higher yields, and a weakening consumer. That mix matters less for the next CPI decimal than for who leads the market in a higher-for-longer regime — and recent retail and pricing data suggest that repricing is not finished.
The post-Nvidia wobble is being mistaken for an AI unwind when the better read is leadership broadening across the same capex cycle. Dell’s guidance reset, plus continued strength in memory, foundry, and custom silicon, argues for selectivity inside AI infrastructure rather than a blanket bubble call.
Symbotic’s selloff on insider-sale headlines looks smaller than the business inflection underneath it. The latest quarter showed real operating leverage, positive net income, and a $2.0 billion cash pile that gives SYM room to keep scaling.
PDD still has growth, but the latest quarter showed that growth is getting more expensive and less profitable. With EPS falling, costs rising faster than revenue, and Temu facing a fresh €200 million EU fine, the market looks right to treat this as lower-quality growth.
PSTG looks like it got hit for lofty expectations, not a broken business. Revenue is still growing at a mid-teens clip, backlog signals stayed strong, and the selloff reads more like a multiple reset than an AI demand unwind.
Synopsys just posted the kind of quarter that usually supports a premium multiple: a revenue beat, higher full-year guidance, and fresh proof it remains critical to leading-edge AI chip design. An 8.6% drop on that setup looks less like a broken story and more like the market handing long-term investors a rare reset entry.
Boston Scientific’s plunge looks like a real reset, not a bargain-bin overreaction. Management already cut 2026 growth guidance, then reinforced that Watchman weakness is tied to a worsening procedure mix that the market can’t just wave away.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator